STAT Plus: Something Ventured: Casma Therapeutics and four other startups got venture funding a year ago. Did it help them do what they said it would?
HYACINTH EMPINADO/STAT
STAT looked at five Boston biotechs — Casma, Accent, Macrolide, Fog, and Cedilla — to see whether they met the goals they set when they got venture funding.
.png)
No hay comentarios:
Publicar un comentario